Tested after a gym day, the Salonpas Pain Relief Patch delivered cooling-warming comfort and targeted relief. Here’s my full review, rating, and which Salonpas is best for you I’ve been in a slow-burn ...
Hisamitsu Pharmaceutical Co. is set to climb to its daily trading limit for a second day after the Japanese maker of ...
FLORHAM PARK, NJ / ACCESS Newswire / April 30, 2025 / Hisamitsu America, the marketers of Salonpas®, the world's No.1 Brand of Over-the-Counter (OTC) topical analgesics in the patch category4, is ...
Chronic pain has become a significantly prevalent issue today. With all the sitting and standing at work, not to forget the long hours, more and more people are experiencing related conditions at such ...
"Salonpas is more than a pain relief patch; it's a symbol of time-tested, trusted medicine that transcends generations," said Bob Arnot, M.D., internal medicine who is a journalist, author and served ...
Global healthcare company, Hisamitsu Pharmaceutical Co. Inc., has launched Salonpas products, which are alternatives to injections and capsules for pain. Executive Officer and Head of the ...
The proposed offer of ¥6,082 per share represents a roughly 35% premium to Hisamitsu’s unaffected closing price on Monday.
Salonpas Day, an annual event in which Hisamitsu America provides thousands of samples of its popular pain patch to consumers, is back. Until COVID-19 hit, Salonpas Day meant distributing samples in ...
The two ads, one featuring an office lady and the other a minibus driver, seek to raise awareness of Salonpas, with a light-hearted depiction of an aching muscle calling out repeatedly for the patch ...
Japan's Hisamitsu Pharmaceutical Co. has said it will go private through a management buyout scheme worth about 390 billion yen. According to Hisamitsu's announcement Tuesday, an asset management ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback